Related references
Note: Only part of the references are listed.Mutational profile of hereditary breast and ovarian cancer-Establishing genetic testing guidelines in a developing country
Ana Krivokuca et al.
CURRENT PROBLEMS IN CANCER (2022)
Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa
Oubaida ElBiad et al.
BMC CANCER (2022)
Real-World Data on Detection of Germline and Somatic Pathogenic/Likely Pathogenic Variants in BRCA1/2 and Other Susceptibility Genes in Ovarian Cancer Patients Using Next Generation Sequencing
Vida Stegel et al.
CANCERS (2022)
Frequency and molecular characteristics ofPALB2-associated cancers in Russian patients
Elena V. Preobrazhenskaya et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Globally Rare BRCA2 Variants With Founder Haplotypes in the South African Population: Implications for Point-of-Care Testing Based on a Single-Institution BRCA1/2 Next-Generation Sequencing Study
Jaco Oosthuizen et al.
FRONTIERS IN ONCOLOGY (2021)
Gene Sequencing for Pathogenic Variants Among Adults With Breast and Ovarian Cancer in the Caribbean
Sophia H. L. George et al.
JAMA NETWORK OPEN (2021)
Prevalence of BRCA1 and BRCA2 Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional Study
Sudeep Gupta et al.
JCO GLOBAL ONCOLOGY (2021)
BRCA1 and BRCA2 mutations in ovarian cancer patients from Belarus: update
Alena Savanevich et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2021)
BRCA1 and BRCA2 germline testing in Cretan isolates reveals novel and strong founder effects
Vivi Apostolou et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Evidence for an ancient BRCA1 pathogenic variant in inherited breast cancer patients from Senegal
Rokhaya Ndiaye et al.
NPJ GENOMIC MEDICINE (2020)
Population Screening for Inherited Predisposition to Breast and Ovarian Cancer
Ranjit Manchanda et al.
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 21, 2020 (2020)
Frequency and spectrum of founder and non-founderBRCA1andBRCA2mutations in a large series of Russian breast cancer and ovarian cancer patients
Anna P. Sokolenko et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
The spectrum of mutations predisposing to familial breast cancer in Poland
Cezary Cybulski et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
BRCA mutation frequency and clinical features of ovarian cancer patients: A report from a Chinese study group
Hualei Bu et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2019)
Pathology of Senegalese breast cancers
Megan Burke Fitzpatrick et al.
PAN AFRICAN MEDICAL JOURNAL (2019)
The yield of full BRCA1/2 genotyping in Israeli high-risk breast/ovarian cancer patients who do not carry the predominant mutations
Inbal Barnes-Kedar et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Cancer Susceptibility Genetic Testing in a High-Risk Cohort of Urban Ashkenazi Jewish Individuals
Sarah M. Nielsen et al.
JOURNAL OF GENETIC COUNSELING (2018)
Ancient genomes from Iceland reveal the making of a human population
S. Sunna Ebenesersdottir et al.
SCIENCE (2018)
BRCA1 and BRCA2 Mutations Other Than the Founder Alleles Among Ashkenazi Jewish in the Population of Argentina
Angela R. Solano et al.
FRONTIERS IN ONCOLOGY (2018)
A Recurrent BRCA2 Mutation Explains the Majority of Hereditary Breast and Ovarian Cancer Syndrome Cases in Puerto Rico
Hector J. Diaz-Zabala et al.
CANCERS (2018)
The yield of targeted genotyping for the recurring mutations in BRCA1/2 in Israel
Rinat Bernstein-Molho et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
The genetic structure of the Belgian population
Jimmy Van den Eynden et al.
HUMAN GENOMICS (2018)
BRCA1 and BRCA2 mutation spectrum - an update on mutation distribution in a large cancer genetics clinic in Norway
Cecilie Heramb et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2018)
BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile
Carolina Alvarez et al.
ONCOTARGET (2017)
Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women
Tom Walsh et al.
JAMA ONCOLOGY (2017)
Genetics in an isolated population like Finland: a different basis for genomic medicine?
Helena Kaariainen et al.
JOURNAL OF COMMUNITY GENETICS (2017)
Prevalence of founder mutations in the BRCA1 and BRCA2 genes among unaffected women from the Bahamas
M. Trottier et al.
CLINICAL GENETICS (2016)
Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in Hungary
Janos Papp et al.
FAMILIAL CANCER (2016)
Spectrum and frequencies of BRCA1/2 mutations in Bulgarian high risk breast cancer patients
Rumyana Ivanova Dodova et al.
BMC CANCER (2015)
Mediterranean Founder Mutation Database (MFMD): Taking Advantage from Founder Mutations in Genetics Diagnosis, Genetic Diversity and Migration History of the Mediterranean Population
Hicham Charoute et al.
HUMAN MUTATION (2015)
Identification of a large set of rare complete human knockouts
Patrick Sulem et al.
NATURE GENETICS (2015)
Genetic Heritage of the Balto-Slavic Speaking Populations: A Synthesis of Autosomal, Mitochondrial and Y-Chromosomal Data
Alena Kushniarevich et al.
PLOS ONE (2015)
High prevalence of BRCA1 founder mutations in Greek breast/ovarian families
I. Konstantopoulou et al.
CLINICAL GENETICS (2014)
The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas
M. R. Akbari et al.
CLINICAL GENETICS (2014)
BRCA1 founder mutations compared to ovarian cancer in Belarus
Alena Savanevich et al.
FAMILIAL CANCER (2014)
Comprehensive BRCA1 and BRCA2 mutational profile in Lithuania
Ramunas Janavicius et al.
CANCER GENETICS (2014)
Haplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations
Yael Laitman et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2013)
Haplotype analysis and ancient origin of the BRCA1 c.4035delA Baltic founder mutation
Ramunas Janavicius et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2013)
High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients
James D. Fackenthal et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Haplotype analysis of two recurrent genomic rearrangements in the BRCA1 gene suggests they are founder mutations for the Greek population
M. Pertesi et al.
CLINICAL GENETICS (2011)
On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations
Nancy Hamel et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2011)
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals
Kirsi M. Kuusisto et al.
BREAST CANCER RESEARCH (2011)
Identification of a novel BRCA1 nucleotide 4803delCC/c.4684delCC mutation and a nucleotide 249T>A/c.130T>A (p.Cys44Ser) mutation in two Greenlandic Inuit families: implications for genetic screening of Greenlandic Inuit families with high risk for breast and/or ovarian cancer
Thomas V. O. Hansen et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Selected Abstracts submitted to the Third International Symposium on Hereditary Breast and Ovarian Cancer
Various Authors
Current Oncology (2010)
A common Greenlandic Inuit BRCA1 RING domain founder mutation
Thomas v. O. Hansen et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
A high frequent BRCA1 founder mutation identified in the Greenlandic population
Theresa Larriba Harboe et al.
FAMILIAL CANCER (2009)
Haplotype of the C61G BRCA1 Mutation in Polish and Jewish Individuals
Bella Kaufman et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2009)
G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients:: evaluation of its pathogenicity and inferences on its genealogical history
Theodore Anagnostopoulos et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Genetic epidemiology of BRCA mutations - family history detects less than 50% of the mutation carriers
Pal Moller et al.
EUROPEAN JOURNAL OF CANCER (2007)
The frequent BRCA1 mutation 1135insA has multiple origins:: a haplotype study in different populations
TM Rudkin et al.
BMC MEDICAL GENETICS (2006)
BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families
K Claes et al.
BRITISH JOURNAL OF CANCER (2004)
A population-genetic test of founder effects and implications for Ashkenazi Jewish diseases
M Slatkin
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
BRCA1 mutations in South African breast and/or ovarian cancer families:: Evidence of a novel founder mutation in Afrikaner families
MD Reeves et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
BRCA2, but not BRCA1, mutations account for familial ovarian cancer in Iceland:: a population-based study
T Rafnar et al.
EUROPEAN JOURNAL OF CANCER (2004)
BRCA1 and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients
L Sarantaus et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2001)
Share Paper
